Pericarditis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2025-07-04
EMA Application withdrawn: Rilonacept FGK Representative Service GmbH (rilonacept) — Rilonacept FGK Representative Service GmbH
EMA has withdrawn the marketing authorization application for rilonacept (Arcalyst) for pericarditis, filed by Rilonacept FGK Representative…